Roskilde / Bergisch Gladbach / Bubendorf / Paris / Stockholm / Villejuif / Illkirch / San Jose / Bromma / Rochester / Meylan / Sundbyberg / Foster City / Erembodegem / /
Company
AddGene Inc. / Bayer HealthCare Pharmaceuticals Inc. / Vector Laboratories / Papavassiliou AG / Transduction Laboratories / Roche Diagnostics / Sigma-Aldrich / Probes Inc. / Papatsoris AG / Applied Biosystems Inc. / BD Biosciences / Bio-Rad / Kodak / Quest software / MitoTracker and co / Sigma-Aldrich Sweden AB / GE / Beckman Coulter / Becton Dickinson / biochemical Co. Hong Kong / Creative Commons / Kim LC / Macmillan Publishers Limited / /
Country
France / Japan / United Kingdom / Denmark / Germany / Sweden / Belgium / Jordan / United States / / /
Facility
Tokyo Metropolitan Institute of Medical Science / University Hospital / National Institute of Genetics / /
IndustryTerm
final dosing solutions / treatment of prostate cancer / cancer therapy / cancer therapeutics / Chemical inhibition / stock solution / chemical inhibitors / prostate cancer treatment / mitogen-activated protein kinase network / therapy of metastatic prostate cancer / prostate cancer therapeutics / chemical inhibitor / /
MedicalCondition
androgen-independent prostate cancer / metastatic prostate cancer / JE / castration-resistant prostate cancer / prostate cancers / prostate cancer / breast cancer / progressive hormone-refractory prostate cancer / prostate carcinomas / lymph node metastases / leukemia / tumor / highly metastatic PC3 cancer / cancer / hepatocellular carcinoma / highly metastatic prostate cancer / Localized prostate cancer / PC3 prostate cancer / Cancer Prostate cancer / primary prostate cancer / human cancers / human prostate cancers / J Cancer / metastatic castration-resistant prostate cancer / non-metastatic prostate cancer / inflammatory cells / renal cell carcinoma / chemo-naive castration-resistant prostate cancer / advanced prostate cancer / Disease / Tumour / PFA / human prostate cancer / both cancer / le Cancer / prostate carcinoma / /
MedicalTreatment
radiotherapy / surgery / cancer therapy / prostatectomy / chemo / chemotherapy / cancer therapeutics / /
OperatingSystem
Petros / /
Organization
National Institute of Genetics / Department of Oncology-Pathology / Tokyo Metropolitan Institute of Medical Science / Universite´ de Nice / Karolinska Institutet and University Hospital / CESAR Central European Society for Anticancer Drug Research-EWIV / Universite´ Paris Descartes / /
Person
Gustave Roussy / Clin Sci / Georges Pompidou / Tamotsu Yoshimori / Ann Oncol / Anders Ulle / Reactive / Noboru Mizushima / Patrik Auberger / / /
Figure 1-Sor kills 22Rv+PC3